Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Double Dose in Diabetic ACS Patients
NCT03329261Phase 4Completed
- Sponsor
- Laboratoires Teriak
- Start
- Dec 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in acute coronary syndrome (ACS), sponsored by Laboratoires Teriak. Started Dec 2017; status: completed.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03329261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329261.